Jagsonpal Pharmaceuticals Limited Total Assets
Jagsonpal Pharmaceuticals Limited total assets. Based on the latest financial reports, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) holds total assets worth Rs3.17 Billion INR (≈ $34.25 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) total market value for the company's overall valuation and market capitalisation.
Total Assets of Jagsonpal Pharmaceuticals Limited (2006–2026)
Total assets of Jagsonpal Pharmaceuticals Limited from 2006 to 2026. This chart illustrates how Jagsonpal Pharmaceuticals Limited's total assets have evolved over time, based on quarterly financial data. See Jagsonpal Pharmaceuticals Limited stock price for real-time trading data and today's change.
Jagsonpal Pharmaceuticals Limited - Asset Composition Analysis
Jagsonpal Pharmaceuticals Limited Total Assets Breakdown (March 2026)
Jagsonpal Pharmaceuticals Limited total assets breakdown as of March 2026. Jagsonpal Pharmaceuticals Limited's total assets of Rs3.17 Billion consist of 45.2% current assets and 54.8% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 3.2% |
| Accounts Receivable | Rs171.91 Million | 5.4% |
| Inventory | Rs146.43 Million | 4.6% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs682.67 Million | 21.6% |
| Goodwill | Rs96.93 Million | 3.1% |
Asset Composition Trend (2006–2026)
This chart illustrates how Jagsonpal Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Jagsonpal Pharmaceuticals Limited to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jagsonpal Pharmaceuticals Limited's current assets represent 45.2% of total assets in 2026, a decrease from 74.1% in 2006.
- Cash Position: Cash and equivalents constituted 3.2% of total assets in 2026, up from 2.8% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is intangible assets at 21.6% of total assets.
Jagsonpal Pharmaceuticals Limited Competitors by Total Assets
Key competitors of Jagsonpal Pharmaceuticals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
|
China | CN¥6.44 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Bide Pharmatech Co. Ltd. A
SHG:688073
|
China | CN¥2.54 Billion |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
|
China | CN¥4.69 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥25.73 Billion |
Jagsonpal Pharmaceuticals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.06 | 6.22 | 2.98 |
| Quick Ratio | 4.54 | 5.64 | 2.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs1.15 Billion | Rs1.35 Billion | Rs800.80 Million |
Jagsonpal Pharmaceuticals Limited - Advanced Valuation Insights
This section examines the relationship between Jagsonpal Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.56 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | 13.8% |
| Total Assets | Rs3.17 Billion |
| Market Capitalization | $154.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jagsonpal Pharmaceuticals Limited's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Jagsonpal Pharmaceuticals Limited's assets grew by 13.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Jagsonpal Pharmaceuticals Limited (2006–2026)
The table below shows the annual total assets of Jagsonpal Pharmaceuticals Limited from 2006 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs3.17 Billion ≈ $34.25 Million |
+13.81% |
| 2025-03-31 | Rs2.78 Billion ≈ $30.09 Million |
+28.18% |
| 2024-03-31 | Rs2.17 Billion ≈ $23.48 Million |
+11.35% |
| 2023-03-31 | Rs1.95 Billion ≈ $21.08 Million |
+15.73% |
| 2022-03-31 | Rs1.68 Billion ≈ $18.22 Million |
+2.59% |
| 2021-03-31 | Rs1.64 Billion ≈ $17.76 Million |
+11.74% |
| 2020-03-31 | Rs1.47 Billion ≈ $15.89 Million |
+8.23% |
| 2019-03-31 | Rs1.36 Billion ≈ $14.68 Million |
+4.60% |
| 2018-03-31 | Rs1.30 Billion ≈ $14.04 Million |
-8.97% |
| 2017-03-31 | Rs1.43 Billion ≈ $15.42 Million |
-10.47% |
| 2016-03-31 | Rs1.59 Billion ≈ $17.23 Million |
+3.28% |
| 2015-03-31 | Rs1.54 Billion ≈ $16.68 Million |
-1.30% |
| 2014-03-31 | Rs1.56 Billion ≈ $16.90 Million |
+2.13% |
| 2013-03-31 | Rs1.53 Billion ≈ $16.55 Million |
-1.98% |
| 2012-03-31 | Rs1.56 Billion ≈ $16.88 Million |
+14.18% |
| 2011-03-31 | Rs1.37 Billion ≈ $14.79 Million |
+10.94% |
| 2010-03-31 | Rs1.23 Billion ≈ $13.33 Million |
+0.38% |
| 2009-03-31 | Rs1.23 Billion ≈ $13.28 Million |
-5.74% |
| 2008-03-31 | Rs1.30 Billion ≈ $14.09 Million |
-11.68% |
| 2007-03-31 | Rs1.47 Billion ≈ $15.95 Million |
+4.19% |
| 2006-03-31 | Rs1.42 Billion ≈ $15.31 Million |
-- |
About Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. … Read more